Exploring the contribution of general self-efficacy to the use of self-care symptom management strategies by people living with HIV infection

Autor: John Arudo, Cathy Bain, Linda Robinson, Mary Jane Hamilton, Dean Wantland, Inge B. Corless, Kenn M. Kirksey, Elizabeth Sefcik, Emily Huang, William L. Holzemer, Carmen J. Portillo, Shanaz Moezzi, Yvette P. Cuca, Patrice K. Nicholas, Sarie Human, Mary Maryland, Sue Willard, María E. Rosa
Rok vydání: 2012
Předmět:
Adult
Male
Nausea
Health Status
Clinical Trials and Supportive Activities
MEDLINE
HIV Infections
Severity of Illness Index
law.invention
Medication Adherence
Quality of life (healthcare)
Randomized controlled trial
7.1 Individual care needs
law
Clinical Research
Virology
Severity of illness
Behavioral and Social Science
medicine
Humans
Longitudinal Studies
Depression (differential diagnoses)
Randomized Controlled Trials as Topic
Self-efficacy
Physician-Patient Relations
business.industry
Public Health
Environmental and Occupational Health

Middle Aged
Health Services
Self Efficacy
Self Care
Infectious Diseases
Mental Health
Good Health and Well Being
Behavioral and Psychosocial Research
Quality of Life
Public Health and Health Services
Anxiety
HIV/AIDS
Female
Management of diseases and conditions
medicine.symptom
business
Clinical psychology
Zdroj: AIDS patient care and STDs, vol 26, iss 6
Popis: General self-efficacy (GSE), the expectation that one is able to perform a behavior successfully, may differentiate those who are able to successfully utilize self-care symptom management strategies (SCSMS). This subanalysis (n=569) of an international 12 site longitudinal randomized controlled trial (RCT) (n=775), investigated GSE as an important factor determining symptom burden, SCSMS, engagement with the provider, and medication adherence over time, and identified differences in those with high and low GSE ratings concerning these variables. Parametric and nonparametric repeated-measures tests were employed to assess GSE and the perceived effectiveness of SCSMS for anxiety, depression, diarrhea, fatigue, nausea, and neuropathy. Symptom burden, engagement with the provider, and antiretroviral adherence were analyzed with regard to GSE. Our data indicated that there were differences in the perceived symptom burden over time of HIV infected individuals by GSE. Those individuals with higher GSE had fewer symptoms and these symptoms were perceived to be less intense than those experienced by the low GSE group. There were few meaningful differences in the SCSMS used by those with high versus low GSE other than the use of illicit substances in the low GSE group. The low GSE group was also significantly (p=
Databáze: OpenAIRE